Black Diamond Therapeutics, Inc. (BDTX) vs Conexeu Sciences Inc. (CNXU)

A side-by-side comparison of Black Diamond Therapeutics, Inc. and Conexeu Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BDTX

Black Diamond Therapeutics, Inc.

$103M

$1.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

CNXU

Conexeu Sciences Inc.

$98M

$3.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BDTX vs CNXU

growth of $100 · dividends reinvested · last 1y

BDTX -46.1% (-46.1%/yr)CNXU -76.1% (-76.1%/yr)BDTX compounded faster over this window

BDTX CNXU

Metrics side by side

Total return (annualized)

Metric	BDTX	CNXU
Total return (1Y)	-49.96%	N/A
Total return CAGR (3Y)	-8.35%	N/A
Total return CAGR (5Y)	-24.47%	N/A

CNXU is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full BDTX analysis Full CNXU analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.